SCHEMBL3525725

SCHEMBL3525725

CCOC(=O)CCN(c1nc(SC)ncc1C(=O)OCC)C1CC2CCC1C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ALDH1A1 P00352 9/20 0.41
▸ MAPT P10636 6/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ SYK P43405 2/20 0.39
▸ HPGD P15428 3/20 0.38
▸ LMNA P02545 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ FOS P01100 1/20 0.37
▸ JUN P05412 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531655 0.83 MEN1 (0.50) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL3291033 0.82 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL12631841 0.78 KMT2A (0.43) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL9955978 0.77 MEN1 (0.51) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL10991726 0.76 ALDH1A1 (0.44) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL4778131 0.76 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL25003607 0.72 ALDH1A1 (0.54) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL22860433 0.72 ALDH1A1 (0.54) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL11020556 0.72 ALDH1A1 (0.55) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL29508799 0.72 ALDH1A1 (0.54) MEN1KMT2AALDH1A1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642270-B2 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA N.V. (BE) 2010-01-05 — — US disclosed
US-20070060577-A1 5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA N.V. (BE) 2007-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060577-A1 5-Oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase FLT3, FES, FGR MEN1 3337/4885KMT2A 1844/4885ALDH1A1 3590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback